Product
Thalidomide+cetuximab+FOLFOX/FOLFIRI
1 clinical trial
1 indication
Clinical trial
Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal CancerStatus: Not yet recruiting, Estimated PCD: 2024-12-31